Bayzed Health (Bayzed Health Group Inc.) reported that shareholders overwhelmingly backed every item on the agenda at the Annual General Meeting (AGM) held on 16 June 2026. All six ordinary resolutions and one special resolution each secured c.99.99% support, reflecting broad shareholder endorsement of the company’s strategy and governance measures.

Key AGM Voting Outcomes • Financial statements and auditor reports for FY2025 were approved with 99.99% of votes cast (979.76 million shares in favour versus 48,600 against).

• Directors’ re-election and remuneration: Eight directors—including four executive and three independent non-executive directors—were re-elected with 99.99% approval. A new executive director, Mr. Lyu Chao, was also appointed with the same level of support.

• Auditor mandate: KPMG’s re-appointment and remuneration arrangement received 99.99% backing.

• Capital mandates: – Share repurchase mandate up to 10% of issued share capital: 99.99% approval. – General issuance mandate up to 20% of issued share capital: 99.99% approval. – Extension of the issuance mandate by the number of shares repurchased: 99.99% approval.

• Special resolution: Shareholders approved amendments to the company’s Articles of Association, adopting a third amended and restated version, with 99.99% in favour.

Board Changes and Authorised Representative Executive Director Mr. Zhao Yongkai retired at the close of the AGM to focus on other commitments. Dr. Chen Haoyang, already an executive director and chairman, has been appointed as the company’s Authorised Representative under Hong Kong Listing Rule 3.05. Mr. Lyu Chao joins the Board as a new executive director effective immediately.

Share Capital and Voting Base As of the AGM date, Bayzed Health had 1.32 billion issued shares, none of which were treasury shares. All shares were eligible to vote, and no shareholder was required to abstain.

Implementation of New Articles The newly adopted Articles of Association take effect immediately. The full text is available on HKEXnews and the company’s website.

The AGM results reinforce shareholder confidence in Bayzed Health’s governance framework while enabling the Board to manage capital and corporate structure with expanded flexibility.